7.06
-0.42 (-5.61%)
| Previous Close | 7.48 |
| Open | 7.12 |
| Volume | 12,421 |
| Avg. Volume (3M) | 75,949 |
| Market Cap | 13,282,956 |
| Price / Sales | 4.06 |
| Price / Book | 0.900 |
| 52 Weeks Range | |
| Earnings Date | 9 Aug 2024 |
| TTM Dividend Yield | 134.56% |
| Profit Margin | 52.46% |
| Operating Margin (TTM) | -153.67% |
| Diluted EPS (TTM) | -24.38 |
| Total Debt/Equity (MRQ) | 1.48% |
| Current Ratio (MRQ) | 4.75 |
| Return on Assets (TTM) | -71.92% |
| Return on Equity (TTM) | -269.31% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Mixed | |
| Stock | TRxADE HEALTH, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Average | -1.50 |
|
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Value |
| % Held by Insiders | 63.99% |
| % Held by Institutions | 10.25% |
No data within this time range.
No data within this time range.
| TTM Dividend Yield | 134.56% |
| 1Y Average Dividend Yield | 0.00% |
| Expected Next Dividend Payment | Mar 2025 |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Cash |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Cash |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |